You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 5, May 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal


Itraconazole as a New Treatment for Pustulosis Palmaris et Plantaris

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Pustulosis palmaris et plantaris (PPP) is a common skin disease that is difficult to treat. We describe 7 patients with PPP in whom the oral administration of itraconazole proved highly effective.

Report of Cases

The clinical data of 7 patients are summarized in Table 1. The patients included 3 men and 4 women ranging in age from 40 to 62 years at the start of administration of itraconazole. The duration of disease before administration of the drug ranged from 7 months to 30 years. All patients started to take itraconazole, 100 mg/d, as an initial dosage and the maintenance dosages were 50 mg/d in 4 patients and 100 mg/d and 50 mg/d alternately in 2 patients. Patient 7 continued to take the initial dosage of 100 mg/d for 6 months without changing to the maintenance dosage. The follow-up periods ranged from 4 weeks to 2 years. In all patients, pustules on the . . . [Full Text of this Article]


Comment






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.